FdaApplication
NDA 020647
Identifiers
- fda_app_no: NDA020647
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 1996-05-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELDEPRYL | SELEGILINE HYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
1 product